273 related articles for article (PubMed ID: 22275179)
1. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.
Khan NA; Lombeida JI; Singh M; Spencer HJ; Torralba KD
Arthritis Rheum; 2012 Jul; 64(7):2059-67. PubMed ID: 22275179
[TBL] [Abstract][Full Text] [Related]
2. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
[TBL] [Abstract][Full Text] [Related]
3. Questioning a publication bias between industry-funded and non-industry-funded randomized controlled trials on biological and small molecule therapy for rheumatoid arthritis.
Cohen N; Lavie RG; Manor Y; Mimouni M; Furst DE; Amarilyo G
Semin Arthritis Rheum; 2020 Feb; 50(1):7-11. PubMed ID: 31280935
[TBL] [Abstract][Full Text] [Related]
4. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis.
Falk Delgado A; Falk Delgado A
Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317
[TBL] [Abstract][Full Text] [Related]
5. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
Als-Nielsen B; Chen W; Gluud C; Kjaergard LL
JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469
[TBL] [Abstract][Full Text] [Related]
6. Outcome reporting among drug trials registered in ClinicalTrials.gov.
Bourgeois FT; Murthy S; Mandl KD
Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.
Montgomery JH; Byerly M; Carmody T; Li B; Miller DR; Varghese F; Holland R
Control Clin Trials; 2004 Dec; 25(6):598-612. PubMed ID: 15588746
[TBL] [Abstract][Full Text] [Related]
8. Influence of study sponsorship on head and neck cancer randomized trial results.
Sun GH; Houlton JJ; MacEachern MP; Bradford CR; Hayward RA
Head Neck; 2013 Oct; 35(10):1515-20. PubMed ID: 22987508
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trials of rheumatoid arthritis registered at ClinicalTrials.gov: what gets published and when.
Khan NA; Singh M; Spencer HJ; Torralba KD
Arthritis Rheumatol; 2014 Oct; 66(10):2664-74. PubMed ID: 25154608
[TBL] [Abstract][Full Text] [Related]
10. Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review.
Mugambi MN; Musekiwa A; Lombard M; Young T; Blaauw R
BMC Med Res Methodol; 2013 Nov; 13():137. PubMed ID: 24219082
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
Bero L; Oostvogel F; Bacchetti P; Lee K
PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
[TBL] [Abstract][Full Text] [Related]
12. Industry funding and the reporting quality of large long-term weight loss trials.
Thomas O; Thabane L; Douketis J; Chu R; Westfall AO; Allison DB
Int J Obes (Lond); 2008 Oct; 32(10):1531-6. PubMed ID: 18711388
[TBL] [Abstract][Full Text] [Related]
13. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
[TBL] [Abstract][Full Text] [Related]
14. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
[TBL] [Abstract][Full Text] [Related]
15. Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?
Golder S; Loke YK
Br J Clin Pharmacol; 2008 Dec; 66(6):767-73. PubMed ID: 18754841
[TBL] [Abstract][Full Text] [Related]
16. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.
Falk Delgado A; Falk Delgado A
Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226
[TBL] [Abstract][Full Text] [Related]
17. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.
Ridker PM; Torres J
JAMA; 2006 May; 295(19):2270-4. PubMed ID: 16705108
[TBL] [Abstract][Full Text] [Related]
18. Funding source and the quality of reports of chronic wounds trials: 2004 to 2011.
Hodgson R; Allen R; Broderick E; Bland JM; Dumville JC; Ashby R; Bell-Syer S; Foxlee R; Hall J; Lamb K; Madden M; O'Meara S; Stubbs N; Cullum N
Trials; 2014 Jan; 15():19. PubMed ID: 24422753
[TBL] [Abstract][Full Text] [Related]
19. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
[TBL] [Abstract][Full Text] [Related]
20. The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
Clark W; Jobanputra P; Barton P; Burls A
Health Technol Assess; 2004 May; 8(18):iii-iv, ix-x, 1-105. PubMed ID: 15130461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
